Assessing interactions for fixed‐dose drug combinations in subcutaneous tumor xenograft studies
14:48 EST 8 Mar 2013 | Wiley Biotechnology Journal
Drug combinations in preclinical tumor xenograft studies are often assessed using fixed doses. Assessing the joint action of drug combinations with fixed doses has not been well developed in the literature. Here, an interaction index is proposed for..
Original Article: Assessing interactions for fixed‐dose drug combinations in subcutaneous tumor xenograft studies
More From BioPortfolio on "Assessing interactions for fixed‐dose drug combinations in subcutaneous tumor xenograft studies"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
